Q‑Heal
Multi-targeted topical therapy for accelerated wound healing and improved scar quality
Q-Heal is a clinically studied, multi-pathway topical system — integrating regenerative, anti-inflammatory, antimicrobial, antioxidant and moisturizing mechanisms across the wound-repair cascade. Antibiotic-free, botanically driven, and ready to fill under your brand.
Two studies. One consistent story.
Healing Score Trajectory (Q-Heal™ n=55 vs Comparator cream n=55, total n=110) and Key Clinical Outcomes (open-label, single-arm, n=60) are reported here exactly as measured — as two distinct evaluations, not combined.
Median day of resolution per assessed parameter, scaled to a 14-day axis. Scar quality assessed separately at Days 20 and 30.
Built for the buyer, backed by the data
Faster healing
May reduce complication risk.
Early pain relief
Supports adherence to the treatment protocol.
Improved cosmetic outcome
Enhances patient satisfaction.
Balanced remodeling
Not closure alone.
Regenerative + antimicrobial
Dual-action bioactive protection.
Clinically superior performance
Vs. comparator, both studies.
Multi-targeted positioning
Regenerative across the wound-repair cascade.
Spray format
Hygienic, touch-free application.
PQNS Delivery
Phytosome Quantum Nano Sphere topical technology — supports cutaneous penetration, stabilization of actives and controlled release with reduced irritation, improving local availability of both lipophilic and hydrophilic actives. Delivery precision without systemic exposure.
Cutaneous penetration
Stabilization of actives
Controlled release with reduced irritation
Local availability of lipophilic & hydrophilic actives
Delivery precision without systemic exposure.
Common questions
Straight answers for distributors, formulators and clinical buyers.
In the open-label, single-arm study (n=60), mean reduction by Day 28 was: Slough clearance – Q-Heal™ 5d vs Comparator cream 11d; Inflammation 5d vs 10d; Pain 4d vs 9d; Discharge & malodour 4d vs 9d; Tenderness 6d vs 12d. Median day of resolution per assessed parameter, scaled to a 14-day axis. Scar quality assessed separately at Days 20 and 30.
Antibiotic-free, botanically driven; well tolerated in surgical and superficial abrasive wounds. 0 serious adverse events reported across 110 subjects.
Centella Triterpenoids: madecassic & asiatic acid, madecassoside, asiaticoside – support fibroblast proliferation, angiogenesis, collagen synthesis & controlled remodeling. Beta-sitosterol + glycyrrhizin: anti-inflammatory & antioxidant activity; helps calm cytokine-mediated tissue reaction. Antimicrobial complex: terpinen-4-ol, alpha-monolaurin, lauric acid & anthraquinone — broad-spectrum protection against bacterial & fungal contamination. Matrix + barrier support: collagen & chondroitin sulphate support ECM formation, moisture retention & epithelial migration; SAPINEODERM® supports barrier restoration.
Scar quality at Day 30 – Q-Heal™: 1.1 mm vs Comparator: 2.4 mm. Mean scar line width — thinner, fainter lines, consistent with balanced collagen remodeling rather than closure alone.
Distributors and partners can contact the Integria Care technical team to request samples, minimum order quantities (MOQ), and the full clinical dossier.
Request samples, MOQ & the full clinical dossier
Talk directly with the Integria Care technical team about formulation details, private-label options and study data.